药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Diphenylpyraline
Selenazole-4-carboxyamide-adenine dinucleotide
The bioavailability of Selenazole-4-carboxyamide-adenine dinucleotide can be decreased when combined with Eltrombopag.
Diphenylpyraline
S-Selanyl Cysteine
The bioavailability of S-Selanyl Cysteine can be decreased when combined with Eltrombopag.
Diphenylpyraline
(S)-2-Amino-3-(6h-Selenolo[2,3-B]-Pyrrol-4-Yl)-Propionic Acid
The bioavailability of (S)-2-Amino-3-(6h-Selenolo[2,3-B]-Pyrrol-4-Yl)-Propionic Acid can be decreased when combined with Eltrombopag.
Diphenylpyraline
Selenomethionine Selenoxide
The bioavailability of Selenomethionine Selenoxide can be decreased when combined with Eltrombopag.
Diphenylpyraline
Selenoinosine
The bioavailability of Selenoinosine can be decreased when combined with Eltrombopag.
Diphenylpyraline
Se-Ethyl-Isoselenourea
The bioavailability of Se-Ethyl-Isoselenourea can be decreased when combined with Eltrombopag.
Diphenylpyraline
Dioxyselenocysteine
The bioavailability of Dioxyselenocysteine can be decreased when combined with Eltrombopag.
Diphenylpyraline
Selenocysteine
The bioavailability of Selenocysteine can be decreased when combined with Eltrombopag.
Diphenylpyraline
4-butyl-5-propyl-1,3-selenazol-2-amine
The bioavailability of 4-butyl-5-propyl-1,3-selenazol-2-amine can be decreased when combined with Eltrombopag.
Diphenylpyraline
Cyproterone acetate
The metabolism of Eltrombopag can be increased when combined with Cyproterone acetate.
Diphenylpyraline
Eluxadoline
The serum concentration of Eluxadoline can be increased when it is combined with Eltrombopag.
Diphenylpyraline
Ferric maltol
Ferric maltol can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diphenylpyraline
Ferric oxyhydroxide
Ferric oxyhydroxide can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diphenylpyraline
Tetraferric tricitrate decahydrate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diphenylpyraline
Ferrous fumarate
Ferrous fumarate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diphenylpyraline
Ferrous succinate
Ferrous succinate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diphenylpyraline
Ferrous gluconate
Ferrous gluconate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diphenylpyraline
Ferric cation
Ferric cation can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diphenylpyraline
Ferric hydroxide
Ferric hydroxide can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diphenylpyraline
Sodium feredetate
Sodium feredetate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.